Please use this identifier to cite or link to this item:
https://doi.org/10.1016/S0044-8486(97)00074-4
Title: | Protection of goldfish against Ichthyophthirius multifiliis by immunization with a recombinant vaccine | Authors: | Jiangyan, H. Zhan, Y. Guoliang, X. Gong, Z. Lam, T.J. Sin, Y.M. |
Keywords: | Ichthyophthirius multifiliis Immune protection Recombinant vaccine |
Issue Date: | 1-Dec-1997 | Citation: | Jiangyan, H., Zhan, Y., Guoliang, X., Gong, Z., Lam, T.J., Sin, Y.M. (1997-12-01). Protection of goldfish against Ichthyophthirius multifiliis by immunization with a recombinant vaccine. Aquaculture 158 (1-2) : 1-10. ScholarBank@NUS Repository. https://doi.org/10.1016/S0044-8486(97)00074-4 | Abstract: | A 316 bp gene fragment containing a potential antigenic epitope of the 48 kDa immobilization antigen of Ichthyophthirius multifiliis (i-AgI) was assembled from six synthetic oligonucleotides and cloned into a bacterial expression vector pGEX2T. The gene construct was introduced into Escherichia coli and the glutathione S-transferase-iAgI (GST-iAgI) fusion protein was successfully expressed. Antisera against GST-iAgI fusion protein from catfish showed a positive reaction with a tomites protein of about 48 kDa, suggesting that the recombinant protein contains an antigenic epitope of i-AgI. Naive goldfish that were immunized with purified GST-iAgI fusion protein were challenged with a lethal dose of infectious tomites of I. multifiliis. The results showed that the average survival rate of the immunized fish was 95% as compared to 55% for the control fish. All these findings suggest that the recombinant GST-iAgI fusion protein can be used as a potential vaccine against the infection of I. multifiliis. | Source Title: | Aquaculture | URI: | http://scholarbank.nus.edu.sg/handle/10635/101471 | ISSN: | 00448486 | DOI: | 10.1016/S0044-8486(97)00074-4 |
Appears in Collections: | Staff Publications |
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.